Head-to-head · Value Score
Gimme Care vs Alan Meds
Two GLP-1 deals, scored on the same six factors. Gimme Care lands a Value Score of 91, Alan Meds a 90. Here's who gives you the honest lower price — and where each one bites back.
Gimme Care
#3 · Grade A · Best Value
Est. first month
$130/mo
Save ~90% vs brand-nameAlan Meds
#5 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameThe verdict
Gimme Care takes it on Value Score, 91 to 90 — an est. $130/mo first month, with no teaser step-up baked in. Alan Meds isn't out of it: Deal-first shoppers who want the cheapest tier on both molecules and an oral option, all in one place.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Gimme Care | Alan Meds |
|---|---|---|
| Value Score | 91 (A) | 90 (A) |
| Est. first month | $130/mo | $99/mo |
| Save vs brand-name | ~90% | ~93% |
| Semaglutide | $130/mo | $99/mo |
| Tirzepatide | $163/mo | $145/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Gimme Care
Genuinely cheap on both molecules ($130 / $163) with a LegitScript-certified pharmacy and all-50-state reach.
Why it's a deal
- Low flat price on both molecules ($130 sema / $163 tirz)
- LegitScript-certified pharmacy
- Available in all 50 states
The fine print
- No brand-name option — compounded only
- No oral/sublingual form
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.